Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward

M. D. Stegall, R. E. Morris, R. R. Alloway, R. B. Mannon

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

The development of new immunosuppressive drugs has slowed markedly over the past several years, and the outlook that improved therapy will be available to the next generation of transplant recipients is bleak. In this viewpoint, the authors outline some of important barriers to new drug development and suggest specific steps that the transplant community can take to overcome them.

Original languageEnglish (US)
Pages (from-to)1094-1101
Number of pages8
JournalAmerican Journal of Transplantation
Volume16
Issue number4
DOIs
StatePublished - Apr 1 2016

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Developing New Immunosuppression for the Next Generation of Transplant Recipients: The Path Forward'. Together they form a unique fingerprint.

Cite this